Highlands Oncology Group-Rogers is a clinical research site located in Rogers, Arkansas, United States 72758.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Highlands Oncology Group-Rogers has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.
Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group-Rogers has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group-Rogers has 10 clinical trials on record, with 2 currently active. Their work covers brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer.
Yes — Highlands Oncology Group-Rogers holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.